No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
B-SOFT Co.,Ltd. operates in the medical and health informatization industry in China. The company provides smart hospital services, including outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and internet + hospital cloud platform. It also offers scientific research big data platform and specialized scientific research platform; clinical laboratory management platform, physical examination management information systems, image storage and communication systems, clinical anesthesia systems, and intensive care information systems; mobile doctor workstation and mobile nursing systems; multidisciplinary team consultation systems; clinical decision support systems; epidemic prevention and control solutions; and Hi-HIS multi-morphic intelligent connectivity management information systems. In addition, the company provides management decision support, smart integrated management, hospital medical insurance risk management, performance management, smart management applications, low-value consumables management systems, high-value consumables traceability management systems, consumables transaction supervision platform, and drug trade supervision platform; smart hospital infrastructure; a multidisciplinary telemedicine platform; and 5G pre-hospital emergency care. Further, it offers smart medical insurance solutions, including medical security information platform, DRG/DIP hospital applications, and single-disease quality management and control. Additionally, the company provides regional collaboration, regional management, primary healthcare, big data national health information platform, women and children’s cloud, and county-level medical consortium, as well as city-level health service platforms. B-SOFT Co.,Ltd. was founded in 1997 and is based in Hangzhou, China.
www.bsoft.com.cnNo one on the platform currently holds 300451.SZ.
No tracked institution reports a position in 300451.SZ as of their last filing.
No one on the platform has traded 300451.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -26.1% | -8.4% | ||||
| Profit Margin % | -38.2% | -4.7% | 6.0% | |||
| Free Cash Flow Margin % | -18.4% | -10.8% | -3.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.1B | -5.1% | $0.03 | $0.03–$0.03 | — | 2 |
| 2027 | $1.2B | +7.2% | $0.04 | $0.04–$0.04 | — | 2 |
| 2028 | $1.3B | +6.0% | $0.05 | $0.04–$0.06 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300451.SZB-SOFT Co.,Ltd. | $3.34 | +0.60% | $5.2B | — |
| 002437.SZHarbin Gloria Pharmaceuticals Co., Ltd | $3.39 | +1.19% | $7.6B | — |
| 300158.SZShanxi Zhendong Pharmaceutical Co.,Ltd | $5.01 | -0.20% | $5.0B | — |
| 300267.SZHunan Er-Kang Pharmaceutical Co., Ltd | $3.16 | +1.94% | $6.5B | — |
| 300288.SZLongmaster Information & Technology Co., Ltd. |
| $9.55 |
| +0.95% |
| $3.2B |
| — |
| 300358.SZTruking Technology Limited | $8.11 | +0.75% | $5.8B | — |
| 300401.SZZhejiang Garden Biopharmaceutical Co.,Ltd. | $15.04 | +4.52% | $8.2B | — |
Source: Financial Modeling Prep · peers by sector/industry